Organic Chemistry TRIZ Cases

Water-soluble TRPV1 prodrugs use pH-dependent release to reduce burning and enable sterile aqueous pain formulations.

A lipopolyplex lipid composition improves intratumoral RNA delivery by balancing tumor targeting, formulation stability, and lower systemic toxicity.

Low-water organic solvent extraction with silica gel and preparative HPLC improves tetrodotoxin recovery while limiting degradation and solvent use.

Bifunctional compounds recruit target proteins to cereblon for selective ubiquitination and degradation across hard-to-modulate protein classes.

Exploiting MTA buildup in MTAP-null cancer cells, these PRMT5 inhibitor compounds improve tumor selectivity while limiting normal-tissue effects.

A polymer-bound sulfonium monomer limits acid diffusion in EUV resist while preserving sensitivity, improving LWR, CDU, and solvent solubility.

Novel curcumin derivatives improve brain delivery and metabolic stability to lower tau oligomers and protect neurons from toxicity.

Ionizable GMO lipids combine protonation and membrane-curvature effects to help RNA LNPs escape endosomes and improve cytosolic delivery.

An induced Ras-cyclophilin A-ligand complex creates a new pocket and sterically blocks effector binding to suppress oncogenic signaling.

In-situ chloromethylation and base-catalyzed hydrolysis raise piperonal purity above 99.5% while cutting tar byproducts and purification steps.

Replacing HOBT with EDC·HCl and HOPO simplifies Edoxaban synthesis, improving purity, yield, and industrial workup.

Dual-target compounds bridge androgen receptor and BRD4 to kill cancer cells while addressing treatment resistance and side effects.

TxA2 receptor antagonism in modified sofalcone derivatives blocks platelet aggregation and thrombosis without the bleeding risk of antiplatelet therapy.

Arylamine compounds improve hole injection, block electron leakage, and maintain stable thin films for lower-voltage, longer-life organic EL elements.

Long-chain or high-boiling carboxylic acids help metal oxide nanoparticle dispersions fill holes and trenches for more uniform films.

Non-toxic carboxylic acids and a water-MEK dual-solvent system convert liamocins to Massoia lactone with scalable separation and less waste.

Small-molecule Ly6K inhibitors block TGFβ and PD-L1 signaling in TNBC, reducing tumor growth and cancer immune suppression.

A2-73 lowers resistant systolic blood pressure through sigma-1 receptor activation, nitric oxide release, and vasodilation.

A thiol-ene intermediate and oxidative cyclization route improves yield, purity, and stability while avoiding corrosive gas generation.

Deuterated arylamine compounds raise thin-film heat stability while preserving hole transport and electron blocking in durable organic EL elements.

Oxide and high-oxide zeolite catalysts hydrolyze ditolyl ether with water to raise cresol conversion and selectivity while avoiding complex base separation.

Recrystallized UV absorber chemistry cuts impurity-driven yellowing while maintaining reduced 410 nm light transmission in spectacle lenses.

A penicillin-surfactant hydrate promoter speeds hydrate formation, raises gas storage capacity, and suppresses bubbles during gas recovery.

Adding trifluoroethylamine before acid activation suppresses dimeric impurities in Fluralaner synthesis, improving yield and purity.

Blending two non-isocyanate polyurethanes enables solvent-free processing, strong epoxy adhesion, and suitable molecular weight without purification.

A Brønsted acid-catalyzed [4+2] cycloaddition turns alkenes into enantioenriched 1,3-amino alcohols in one mild, scalable step.

Adding a terminal alkenyl group to fluorene (meth)acrylate improves cured resin elongation while preserving heat resistance and refractive index.

A delayed fluorescent assist dopant converts triplet excitons into singlet emission, raising OLED light efficiency with tuned energy levels.

Tuned polymer polarity, xylene dissolution rate, and viscosity keep a cover film bonded to glass after long-term sample storage.

Methyl and nitrile cycloheptane derivatives boost fragrance stability, diffusivity, and sensory richness while reducing blend complexity at low dosage.

Selective N-phenylcarbamoyl compounds inhibit Fyn and VEGFR2 locally to treat pain, inflammation, and cancer with lower systemic toxicity.

Functionalized benzamide derivatives activate the cGAS-STING pathway while improving cell permeability and metabolic stability for antiviral and antitumor immunity.

A water-immiscible solvent blend extracts furfural during sugar dehydration, cutting humins, reactor fouling, and separation energy.

A small molecule ligand binds the UBR box domain to block substrate binding and suppress degradation in UBR-related disease treatment.

Selective imidazopyridine and aza-imidazopyridine compounds inhibit JAK2 to treat hematologic neoplasms while limiting off-target kinase effects.

Small molecules modulate pre-mRNA splicing while avoiding oligonucleotide limits in oral delivery, BBB penetration, and RNA access.

A staged halogenation, Suzuki coupling, and deprotection route improves ELQ yield and purity while making large-scale synthesis practical.

Deuterium-substituted emitters in a composite OLED light-emitting layer lower driving voltage while improving efficiency and lifetime.

Specific kinase inhibitor compounds improve inhibition of EGFR and Her2 exon 20 mutations, addressing low response rates seen with current drugs.

Small molecules that bind cGAS suppress pathological cytokine production, enabling treatment of autoimmune and systemic inflammatory disease.

Polymer-bound onium salt monomers limit acid diffusion while preserving sensitivity, improving LWR, contrast, and EUV resist patterning.

A radical cyclization and Suzuki coupling route delivers isomerically pure mTOR inhibitor intermediates at scalable cost without tedious chromatography.

By targeting SOS1 instead of direct RAS binding, this composition improves RAS-pathway inhibition and reduces tumor cell survival in KRAS cancers.

A telescoped isocyanate-based route raises Compound A purity and yield while cutting solvent use, by-products, and scale-up burden.

A tailored clarifying compound improves polyolefin transparency while resisting yellowing, thermal decomposition, and poor resin dispersion.

Targeting DPP-4 with thienopyrimidinone compounds helps reduce collagen deposition and fibrotic gene expression in liver fibrosis.

High-purity oral CBD uses beta-caryophyllene and antioxidants to limit THC impurities, preserve potency, and support precise dosing.

Formula (1) compounds in the organic semiconductor layer improve electron injection and transport, lowering OLED voltage and power use.

Triarylbenzene-based arylamine compounds improve hole injection, electron blocking, and thin-film stability to extend organic EL lifetime.

Selective triazolotriazine A2A antagonists block adenosine signaling to reverse T cell anergy and strengthen anti-tumor immunity.

A 3-tetrazolylmethyl-1,3,5-triazin-2,4-dione compound inhibits SARS-CoV-2 3CL protease activity with high in-vitro safety.

Anthraquinone compounds activate BK channels to reduce smooth muscle excitability, avoiding systemic side effects of muscarinic antagonists.

Covalent SuFEx warheads extend receptor blockade beyond fentanyl half-lives, preventing re-narcotization.

A novel heterocyclic compound enhances organic light emitting device efficiency through optimized molecular structure.

Sulfonyl azide cross-linking agents with organic spacer chains eliminate explosive phlegmatizing agents in polymer manufacturing.

Modified Sudan Black B compounds target lipofuscin in archival tissues, overcoming the operational complexity of fresh sample requirements.

A size exclusion filter separates small byproducts from larger cannabis compounds, resolving the trade-off between extraction speed and compound retention.

Formula I compounds inhibit PI3K delta activity via localized binding pockets, resolving selectivity challenges to treat cancer and autoimmune diseases.

Fluorinated supramolecular polymers form hydrogen bonds to enable solvent-free processing, eliminating toxic solvents while maintaining protective properties.

Formula I compounds inhibit ASK1 kinase activity to treat neurodegenerative and cardiovascular disorders by blocking oxidative stress pathways.

Heating the mixture to 160°C enables high-yield synthesis and easy separation from hazardous byproducts.

Fluorinated acid generators balance lithography resolution and alkali solubility, preventing pattern defects from poor development.

Amine-substituted aryl compounds inhibit histone methyltransferase activity to treat sickle cell anemia.

Arylsulphone-containing benzoxazine component compatibilizes polyarylsulphone toughening agents within the resin matrix.

Deep eutectic solvent replaces ionic liquids to reduce toxicity while aerogel porosity expands the electrochemical window for stable cyclic performance.

Fluorinated phenothiazine shuttles oxidize at 4.3 V to mitigate overcharge in high-voltage cells, extending cycle life beyond dozens of cycles.

Sterically hindered amino alcohols reduce energy consumption and solvent losses during CO2 capture regeneration.

Chromatography isolates a benzopyran compound that suppresses lung fibroblast proliferation with lower toxicity than corticosteroids.

Specific polycyclic compounds resolve the trade-off between current efficiency and device lifetime by optimizing energy levels.

Nitrogen-containing compounds with triazine groups facilitate delayed fluorescence emission in organic electroluminescence devices.

Heterocyclic amide and urea compounds bind the JAK2 kinase domain to inhibit enzymatic activity.

Calcium lignin sulfonate replaces scarce molybdenum disulfide in lubricating greases, providing enhanced load carrying capacity and oxidation resistance.

Acyl sulfonamide compounds target KAT6A overexpression to restore histone acetylation and suppress tumor progression in ER+ HER2- breast cancer.

A non-ionic compound with alicyclic and perfluoroalkyl groups forms a resist composition that improves pattern resolution.

BTZ-N3 compounds utilize ambident azide electrophiles to inhibit the DprE1 enzyme in Mycobacterium tuberculosis.

Formula I compounds restore CFTR function to increase anion secretion, correcting inadequate hydration and mucus clearance in cystic fibrosis.

Replacing calcium carbonate with barium sulphate eliminates hygroscopy and acid sensitivity, preventing segregation in coating applications.

Replacing metal salts with anhydride-derived amides and sulfonates eliminates environmental hazards while preventing moisture corrosion on metal surfaces.

Formula I adamantane compounds inhibit filovirus replication by blocking glycoprotein-mediated cell entry, addressing high mortality rates.

A zeolitic catalyst with controlled medium acid sites drives acetone-ammonia cyclocondensation.

Novel 4-aryl-6-piperazin-1-yl-3-substituted-pyridazine compounds act as fast dissociating dopamine 2 receptor antagonists.

Solvent extraction isolates lactic acid from fermentation broth, avoiding carbohydrate contamination that reduces polymerization yield.

Heteroaromatic polycyclic fused compounds enhance oxidation stability and lifespan while reducing operating voltage in phosphorescent emission layers.

Tri-substituted purines modulate inflammatory responses to reverse blood-brain barrier leakage, addressing limited hypothermia effectiveness.

Specific alkyl and aryl substituents on the xanthene core prevent thermal degradation and clogging during elevated temperature inkjet printing.

A zolpidem tablet-in-tablet dosage form uses a binder-rich outer coating layer to ensure physical stability and adhesion.

Segmented radiolabeled dihydrotrabenazine compounds bind specifically to VMAT2 receptors, enabling accurate diagnosis of neurodegenerative diseases.

Adjusting the pH of a 3-alkenylcephem solution converts amine salts to free acids, resolving filtration inefficiencies and boosting Z-isomer yield.

Phase-transfer catalysis converts cyclopropyl aryl ketones to gamma-halo ketones, suppressing cyclisation by-products and improving yield.

A fluorine-containing ether compound forms a thin lubricating layer on magnetic recording media.

Hydrothermal conversion of FAU zeolites with defined organic structuring agents yields high purity AFX structures for catalytic applications.

Alkoxylated co-solvents reduce chemical costs by lowering microemulsion viscosity and improving aqueous stability during enhanced oil recovery.

Ketone linked benzothiazole compounds inhibit endothelial lipase to treat dyslipidemias and manage atherosclerosis risk.

Segmented degrader molecules bridge target proteins like KRAS to the LC3B autophagy adapter, resolving specificity limits in toxic aggregate removal.

Activating a reduced manganese copper catalyst with hydrogen at 300 to 400 degrees Celsius enhances robustness and selectivity.

A composite material system using an indole derivative host and dopant overcomes single-layer limitations to boost color purity and device lifespan.

Carbazole-based hole transport and benzimidazole electron layers boost luminous efficiency while extending emission lifetime without increasing driving voltage.